For most appropriate candidates, yes, when the PRP is calibrated high-dose, delivered under live ultrasound, by a physician with the right training. For the wrong indication, the wrong dose, or the wrong delivery, PRP can fail to deliver and cost the patient twice. Here is the honest breakdown.
The Short Answer
Whether PRP is worth it comes down to four factors: the indication (right diagnosis), the dose (calibrated high-dose vs standard single-spin), the targeting (live ultrasound vs unguided), and the provider (physician-delivered vs technician). Get all four right and PRP is one of the most cost-efficient regenerative tools in orthopaedic medicine. Get one wrong and it is the most common reason patients end up paying twice. You want to be the patient who started here, not the patient who got here after the failed first try elsewhere.
When PRP is worth it?
PRP delivers measurable improvement in pain, function, and disease progression when the right four factors line up:
- The right indication. Chronic tendinopathy (plantar fasciitis, tennis/golfer’s elbow, patellar tendinopathy, proximal hamstring, Achilles), partial rotator cuff tears, early-to-moderate knee and hip osteoarthritis, ligament sprains, and calcific shoulder tendinopathy all respond well. Advanced bone-on-bone arthritis usually needs Dynamic Stem Cell+ instead of or in addition to PRP.
- The right dose. Calibrated multi-spin PRP at 12-20 times whole-blood baseline (Dynamic PRP+ standard, over 10 billion platelets per dose) outperforms standard single-spin kits at 2-3x baseline. Higher dose, higher first-attempt success.
- The right targeting. Live ultrasound guidance at every injection confirms the target, avoids adjacent structures, and verifies delivery. Unguided injections miss the target tissue more often.
- The right provider. Physician-delivered injection by a sports medicine-trained physician outperforms technician delivery. Every PRP at Dynamic Athlete is performed by Dr. Garg personally.
What the evidence shows?
A multi-center randomized trial of leukocyte-poor PRP for knee osteoarthritis showed significantly greater pain relief and function compared to hyaluronic acid and corticosteroid, with cartilage volume on MRI showing roughly 50% less progression at five years in the PRP arm. Additional published evidence supports PRP for chronic tendinopathy, partial rotator cuff tears, and bone stress injuries.
PRP does not regrow cartilage at scale. What it does, supported by RCT data, is reduce pain, improve function, and slow disease progression. That is the realistic expectation, and that is what makes PRP worth it for the right patient.
The Cost-per-Outcome Math
Over 90% of our patients self-report a 75% or greater improvement. Calculated against the Dynamic PRP+ protocol cost, that delivers a cost-per-outcome math that beats both lower-dose PRP at a lower price (lower success rate, often pays twice) and the alternative surgical pathway (anesthesia, weeks of recovery, time off work, revision risk).
When PRP is not worth it?
Honest answer: PRP is not worth it for everyone. Indications where PRP under-delivers or fails to deliver include very advanced bone-on-bone arthritis with severe deformity (Dynamic Stem Cell+ or surgical referral usually warranted), full-thickness rotator cuff tears with retraction (often surgical), and structural injuries that require mechanical repair rather than biologic stimulation.
At the consult we evaluate imaging and exam to give you a candid answer: yes you are a candidate, no this is not regenerative territory, or yes with a specific staged plan.
Frequently asked questions
Is PRP worth it?
For most appropriate candidates, yes. Whether PRP is worth it depends on four things: the indication (tendinopathy, partial tear, early-to-moderate osteoarthritis respond well; advanced bone-on-bone disease usually needs more), the dose (calibrated multi-spin at 12 to 20 times whole-blood baseline outperforms standard single-spin at 2 to 3 times baseline), the targeting (live ultrasound at every injection beats unguided injection), and the provider (physician-delivered injection beats technician delivery). At Dynamic Athlete, over 90% of our patients self-report a 75% or greater improvement following treatment, calculated against this Dynamic PRP+ protocol.
Does PRP actually work?
Yes, supported by a substantial published evidence base. A multi-center randomized trial of leukocyte-poor PRP for knee osteoarthritis showed significantly greater pain relief and function compared to hyaluronic acid and corticosteroid, with cartilage volume on MRI showing roughly 50% less progression at five years in the PRP arm. Additional published evidence supports PRP for chronic tendinopathy (plantar fasciitis, lateral epicondylitis, patellar tendinopathy, proximal hamstring), partial rotator cuff tears, and other indications. PRP does not regrow cartilage at scale. It does reduce pain, improve function, and slow progression.
What is the success rate of PRP at Dynamic Athlete?
Over 90% of our patients self-report a 75% or greater improvement following treatment. This success rate reflects the Dynamic PRP+ protocol: calibrated multi-spin PRP at approximately 12 to 20 times baseline whole-blood platelet concentration, over 10 billion platelets per dose, paired with exosome-containing fibrin-rich plasma, delivered under live ultrasound by Dr. Aneesh Garg, DO, CAQ personally. The success rate of standard single-spin PRP delivered without ultrasound or physician oversight is materially lower.
What conditions respond best to PRP?
Chronic tendinopathy (plantar fasciitis, lateral and medial epicondylitis, patellar tendinopathy, proximal hamstring, Achilles), partial rotator cuff tears, early-to-moderate knee and hip osteoarthritis, ligament sprains, and calcific shoulder tendinopathy all respond well to high-dose PRP under live ultrasound. Advanced bone-on-bone arthritis often needs Dynamic Stem Cell+ instead of or in addition to PRP. We determine the right protocol at the consult based on imaging and exam.
Is PRP worth the cost compared to cortisone or surgery?
Compared to cortisone, yes for most chronic indications: cortisone delivers fast pain relief but wanes over weeks to months, and repeated intra-articular cortisone has been associated with greater cartilage volume loss compared with saline at 24 months in a randomized trial (McAlindon et al. JAMA 2017). Published RCTs and systematic reviews consistently show PRP outperforming cortisone and hyaluronic acid at 6 and 12 months for knee osteoarthritis and chronic tendinopathy (Patel et al. AJSM 2013; Belk et al. AJSM 2021 meta-analysis). Compared to surgery, PRP is significantly less expensive when you count surgical center fees, anesthesia, weeks of rehabilitation, time off work, and revision risk. For patients staging off or avoiding surgery, the PRP investment frequently pays for itself in lost-income avoidance alone.
How long does PRP take to work?
PRP works by stimulating tissue repair rather than suppressing inflammation, so the timeline is gradual. Most patients notice improvement within a few weeks of treatment. We continuously evaluate response and consider whether a second injection or escalation is warranted. Some indications (chronic tendinopathy, partial tears) respond faster than others, but the directional improvement curve is consistent.